|
1
|
Roy LO, Poirier MB and Fortin D:
Transforming growth factor-beta and its implication in the
malignancy of gliomas. Target Oncol. 10:1–14. 2015. View Article : Google Scholar
|
|
2
|
Osswald M, Jung E, Sahm F, Solecki G,
Venkataramani V, Blaes J, Weil S, Horstmann H, Wiestler B, Syed M,
et al: Brain tumour cells interconnect to a functional and
resistant network. Nature. 528:93–98. 2015.PubMed/NCBI
|
|
3
|
Tao T, Cheng C, Ji Y, Xu G, Zhang J, Zhang
L and Shen A: Numbl inhibits glioma cell migration and invasion by
suppressing TRAF5-mediated NF-κB activation. Mol Biol Cell.
23:2635–2644. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bai RY, Staedtke V and Riggins GJ:
Molecular targeting of glioblastoma: Drug discovery and therapies.
Trends Mol Med. 17:301–312. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qazi MA, Vora P, Venugopal C, McFarlane N,
Subapanditha MK, Murty NK, Hassell JA, Hallett RM and Singh SK: A
novel stem cell culture model of recurrent glioblastoma. J
Neurooncol. 126:57–67. 2016. View Article : Google Scholar
|
|
6
|
Ding Z, Liu Y, Yao L, Wang D, Zhang J, Cui
G, Yang X, Huang X, Liu F and Shen A: Spy1 induces
de-ubiquitinating of RIP1 arrest and confers glioblastoma's
resistance to tumor necrosis factor (TNF-α)-induced apoptosis
through suppressing the association of CLIPR-59 and CYLD. Cell
Cycle. 14:2149–2159. 2015. View Article : Google Scholar :
|
|
7
|
Takeyama K, Aguiar RC, Gu L, He C, Freeman
GJ, Kutok JL, Aster JC and Shipp MA: The BAL-binding protein BBAP
and related Deltex family members exhibit ubiquitin-protein
isopeptide ligase activity. J Biol Chem. 278:21930–21937. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Y, Mao D, Roswit WT, Jin X, Patel
AC, Patel DA, Agapov E, Wang Z, Tidwell RM, Atkinson JJ, et al:
PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C
protease to enhance interferon signaling and control viral
infection. Nat Immunol. 16:1215–1227. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Holleman J and Marchese A: The ubiquitin
ligase deltex-3l regulates endosomal sorting of the G
protein-coupled receptor CXCR4. Mol Biol Cell. 25:1892–1904. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan Q, Dutt S, Xu R, Graves K, Juszczynski
P, Manis JP and Shipp MA: BBAP monoubiquitylates histone H4 at
lysine 91 and selectively modulates the DNA damage response. Mol
Cell. 36:110–120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yan Q, Xu R, Zhu L, Cheng X, Wang Z, Manis
J and Shipp MA: BAL1 and its partner E3 ligase, BBAP, link
Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA
repair independent of ATM, MDC1, and RNF8. Mol Cell Biol.
33:845–857. 2013. View Article : Google Scholar :
|
|
12
|
Thang ND, Yajima I, Kumasaka MY, Iida M,
Suzuki T and Kato M: Deltex-3-like (DTX3L) stimulates metastasis of
melanoma through FAK/PI3K/AKT but not MEK/ERK pathway. Oncotarget.
6:14290–14299. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bachmann SB, Frommel SC, Camicia R,
Winkler HC, Santoro R and Hassa PO: DTX3L and ARTD9 inhibit IRF1
expression and mediate in cooperation with ARTD8 survival and
proliferation of metastatic prostate cancer cells. Mol Cancer.
13:1252014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kolchinsky A and Roninson IB: Drug
resistance conferred by MDR1 expression in spheroids formed by
glioblastoma cell lines. Anticancer Res. 17:3321–3327.
1997.PubMed/NCBI
|
|
15
|
Günther W, Pawlak E, Damasceno R, Arnold H
and Terzis AJ: Temozolomide induces apoptosis and senescence in
glioma cells cultured as multicellular spheroids. Br J Cancer.
88:463–469. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stoops SL, Waterson AG, An H, Deane N,
Daniels JS, Morrison R, Engers JL, Beauchamp D and Lindsley CW:
Discovery and characterization of a small molecule that restores
E-cadherin expression in cancer cell lines via a new mechanism.
Probe Reports from the NIH Molecular Libraries Program (Internet).
Bethesda (MD): National Center for Biotechnology Information (US);
2010–2012 Dec 13. (updated 2013 Mar 22). Available from: https://www.ncbi.nlm.nih.gov/books/NBK344134/.
|
|
17
|
Lindsay CR, Le Moulec S, Billiot F, Loriot
Y, Ngo-Camus M, Vielh P, Fizazi K, Massard C and Farace F: Vimentin
and Ki-67 expression in circulating tumour cells derived from
castrate-resistant prostate cancer. BMC Cancer. 16:1682016.
View Article : Google Scholar
|
|
18
|
Castro GN, Cayado-Gutiérrez N, Zoppino FC,
Fanelli MA, Cuello-Carrión FD, Sottile M, Nadin SB and Ciocca DR:
Effects of temozolomide (TMZ) on the expression and interaction of
heat shock proteins (HSPs) and DNA repair proteins in human
malignant glioma cells. Cell Stress Chaperones. 20:253–265. 2015.
View Article : Google Scholar :
|
|
19
|
Zhuang D, Liu Y, Mao Y, Gao L, Zhang H,
Luan S, Huang F and Li Q: TMZ-induced PrPc/par-4 interaction
promotes the survival of human glioma cells. Int J Cancer.
130:309–318. 2012. View Article : Google Scholar
|
|
20
|
Ogbomo H, Cinatl J Jr, Mody CH and Forsyth
PA: Immunotherapy in gliomas: Limitations and potential of natural
killer (NK) cell therapy. Trends Mol Med. 17:433–441. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rich JN and Bigner DD: Development of
novel targeted therapies in the treatment of malignant glioma. Nat
Rev Drug Discov. 3:430–446. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ding Z, Liu X, Liu Y, Zhang J, Huang X,
Yang X, Yao L, Cui G and Wang D: Expression of far upstream element
(FUSE) binding protein 1 in human glioma is correlated with c-Myc
and cell proliferation. Mol Carcinog. 54:405–415. 2015. View Article : Google Scholar
|
|
23
|
Chen J, Sun J, Yang L, Yan Y, Shi W, Shi
J, Huang Q, Chen J and Lan Q: Upregulation of B23 promotes tumor
cell proliferation and predicts poor prognosis in glioma. Biochem
Biophys Res Commun. 466:124–130. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Juszczynski P, Kutok JL, Li C, Mitra J,
Aguiar RC and Shipp MA: BAL1 and BBAP are regulated by a gamma
interferon-responsive bidirectional promoter and are overexpressed
in diffuse large B-cell lymphomas with a prominent inflammatory
infiltrate. Mol Cell Biol. 26:5348–5359. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xu H, Tian Y, Yuan X, Liu Y, Wu H, Liu Q,
Wu GS and Wu K: Enrichment of CD44 in basal-type breast cancer
correlates with EMT, cancer stem cell gene profile, and prognosis.
Onco Targets Ther. 9:431–444. 2016.PubMed/NCBI
|
|
26
|
Li RY, Chen LC, Zhang HY, Du WZ, Feng Y,
Wang HB, Wen JQ, Liu X, Li XF, Sun Y, et al: MiR-139 inhibits Mcl-1
expression and potentiates TMZ-induced apoptosis in glioma. CNS
Neurosci Ther. 19:477–483. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan Y, Xu Z, Dai S, Qian L, Sun L and Gong
Z: Targeting autophagy to sensitive glioma to temozolomide
treatment. J Exp Clin Cancer Res. 35:232016. View Article : Google Scholar : PubMed/NCBI
|
